Twelve Infants Perish in Clinical Trial for RSV Shot - FDA Recommends Anyway

First published at 20:57 UTC on June 12th, 2023.


Four of the twelve infants’ deaths in the AstraZeneca trial were from cardiac arrest, and two died of SIDS (Sudden Infant Death Syndrome).

The FDA claimed the deaths were “unrelated” to AstraZeneca’s monoclonal antibody injection, but how often do …

MORE
CategoryHealth & Medical
SensitivityNormal - Content that is suitable for ages 16 and over
DISCUSS THIS VIDEO